Top

Gepubliceerd in:

11-01-2016 | Artikel

Is er een typisch neuropsychologisch profiel bij volwassenen met ADHD? Een ontwikkelingsperspectief

Auteurs: Hyke G. H. Tamminga, Hilde M. Geurts

Gepubliceerd in: Neuropraxis | Uitgave 1/2016

Samenvatting

Er is in de afgelopen decennia uitgebreid onderzoek gedaan naar cognitieve problemen bij kinderen, maar ook naar cognitieve problemen bij volwassenen met de gedragsdiagnose ADHD. Het idee is dat de geobserveerde symptomen te relateren zijn aan executieve functieproblemen, delay-aversion, tijdverwerking en arousal. Dit betekent niet dat er een typisch neuropsychologisch profiel is voor volwassenen met ADHD. We zien dat de cognitieve problemen vaak nog aanwezig blijven als de gedragsproblemen afnemen, maar hierbij is de vraag in welke mate de cognitieve problemen gerelateerd zijn aan ADHD of juist het gevolg zijn van langdurig medicatiegebruik. Daarnaast is sprake van veel heterogeniteit in het type cognitieve problemen dat volwassenen met een ADHD-diagnose nog hebben. Er kan naar onze mening dus niet gesproken worden van een typisch neuropsychologisch ADHD-profiel. In dit kwalitatieve overzichtsartikel zal dit geïllustreerd worden op basis van een serie recente bevindingen.

vorige artikel ADHD bij volwassenen: ontwikkelingen in Nederland en Europa

volgende artikel Autorijden met ADHD

American Psychiatric Association [APA]. Diagnostic and Statistical Manual of Mental Disorders. 5. edn. Washington, DC: American Psychiatric Association [APA]; 2013.CrossRef

Boyle CA, Boulet S, Schieve LA, Cohen, RA, Blumberg SJ, Yeargin-Allsopp M, et al. Trends in the prevalence of developmental disabilities in US children, 1997–2008. Pediatrics. 2011;127:1034–42.

Merikangas KR, He JP, Brody D, Fisher PW, Bourdon K, Koretz DS. Prevalence and treatment of mental disorders among US children in the 2001–2004 NHANES. Pediatrics. 2010;125:75–81.CrossRefPubMedPubMedCentral

Barbaresi WJ, Colligan RC, Weaver AL, Voigt RG, Killian JM, Katusic SK. Mortality, ADHD, and psychosocial adversity in adults with childhood ADHD: a prospective study. Pediatrics. 2013;131:637–44.CrossRefPubMedPubMedCentral

Faraone SV, Biederman J. What is the prevalence of adult ADHD? results of a population screen of 966 adults. J Atten Disord. 2005;9:384–91.CrossRefPubMed

Fayyad J, Graaf R de, Kessler R, Alonso J, Angermeyer M, Demyttenaere K, et al. Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Brit J Psychiat. 2007;190:402–09.CrossRefPubMed

Michielsen M, Semeijn E, Comijs HC, Ven P van de, Beekman ATF, Deeg DJH, et al. Prevalence of attention-deficit hyperactivity disorder in older adults in The Netherlands. Brit J Psychiat. 2012;201:298–305.CrossRefPubMed

Biederman J, Petty CR, Ball SW, Fried R, Doyle AE, Cohen D, et al. Are cognitive deficits in attention deficit/hyperactivity disorder related to the course of the disorder? A prospective controlled follow-up study of grown up boys with persistent and remitting course. Psychiat Res. 2009;170:177–82.CrossRef

McAuley T, Crosbie J, Charach A, Schachar R. The persistence of cognitive deficits in remitted and unremitted ADHD: a case for the state-independence of response inhibition. J Child Psychol Psychiat. 2014;55:292–300.CrossRefPubMedPubMedCentral

10.

Bédard AC, Trampush JW, Newcorn JH, Halperin JM. Perceptual and motor inhibition in adolescents/young adults with childhood-diagnosed ADHD. Neuropsychol. 2010;24:424–34.CrossRef

11.

Fuermaier ABM, Tucha L, Koerts J, Aschenbrenner S, Weisbrod M, Lange KW, et al. Cognitive complaints of adults with attention deficit hyperactivity disorder. Clin Neuropsychol. 2014;28:1104–22.CrossRefPubMed

12.

Fuermaier ABM, Tucha L, Koerts J, Aschenbrenner S, Kaunzinger I, Hauser J, et al. Cognitive impairment in adult ADHD – perspective matters! Neuropsychol. 2015;29:45–58.CrossRef

13.

Giedd JN, Blumenthal J, Jeffries NO, Castellanos FX, Liu H, Zijdenbos A, et al. Brain development during childhood and adolescence: a longitudinal MRI study. Nat Neurosci. 1999;2:861–63.CrossRefPubMed

14.

Westlyle LT, Walhovd KB, Dale AM, Bjørnerud A, Due-Tønnessen P, Engvig A, et al. Life-span changes of the human brain white matter: Diffusion Tensor Imaging (DTI) and volumetry. Cereb Cortex. 2010;20:2055–68.CrossRef

15.

Shaw P, Eckstrand K, Sharp W, Blumenthal J, Lerch JP, Greenstein D, et al. Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation. Proc Nat Acad Sci. 2007;104:19649–54.CrossRefPubMedPubMedCentral

16.

Shaw P, Malek M, Watson B, Greenstein D, Rossi P de, Sharp W. Trajectories of cerebral cortical development in childhood and adolescence and adult attention-deficit/hyperactivity disorder. Biol Psychiat. 2013;74:599–606.CrossRefPubMed

17.

Shaw P, Sharp WS, Morrison M, Eckstrand K, Greenstein DK, Clasen LS, Evans AC, Rapoport JL. Psychostimulant treatment and the developing cortex in attention-deficit/hyperactivity disorder. Am J Psychiat. 2009;166:58–63.CrossRefPubMedPubMedCentral

18.

Mostofsky SH, Cooper KL, Kates WR, Denckla MB, Kaufmann WE. Smaller prefrontal and premotor volumes in boys with attention-deficit/hyperactivity disorder. Biol Psychiat. 2002;52:785–94.CrossRefPubMed

19.

Krain AL, Castellanos FX. Brain development and ADHD. Clin Psychol Rev. 2006;26:433–44.CrossRefPubMed

20.

Durston S. A review of the biological bases of ADHD: what have we learned from imaging studies? Ment Retard Dev Disabil. 2003;9:184–95.CrossRef

21.

Mackie S, Shaw P, Lenroot R, Pierson R, Greenstein DK, Nugent TF, et al. Cerebellar development and clinical outcome in attention deficit hyperactivity disorder. Am J Psychiat. 2007;164:647–55.CrossRefPubMed

22.

Hart H, Radua J, Nakao T, Mataix-Cols D, Rubia K. Meta-analysis of functional magnetic resonance imaging studies of inhibition and attention in attention-deficit/hyperactivity disorder: exploring task-specific, stimulant medication, and age effects. Arch Gen Psychiat. 2013;70:185–98.

23.

Castellanos FX, Proal E. Large-scale brain systems in ADHD: beyond the prefrontal–striatal model. Trends Cog Sci. 2012;16:17–26.CrossRef

24.

Konrad K, Eickhoff SB. Is the ADHD brain wired differently? a review on structural and functional connectivity in attention deficit hyperactivity disorder. Hum Brain Mapp. 2010;31:904–16.CrossRefPubMed

25.

Castellanos FX, Sonuga-Barke ESJ, Milham MP, Tannock R. Characterizing cognition in ADHD: beyond executive dusfunction. Trends Cogn Sci. 2006;10:117–23.CrossRefPubMed

26.

Stuss DT. Functions of the frontal lobes: relation to executive functions. J Int Neuropsychol Soc. 2011;17:759–65.CrossRefPubMed

27.

Doyle AE. Executive functions in attention-deficit/hyperactivity disorder. J Clin Psychiat. 2006;67:21–6.

28.

Kasper LJ, Alderson M, Hudec KL. Moderators of working memory deficits in children with attention-deficit/hyperactivity disorder (ADHD): a meta-analytic review. Clin Psychol Rev. 2012;32:605–17.CrossRefPubMed

29.

Huang-Pollock CL, Karalunas SL, Tam H, More AN. Evaluating vigilance deficits in ADHD: a meta-analysis of CPT performance. J Abnorm Psychol. 2012;121:360–71.CrossRefPubMedPubMedCentral

30.

Andersen PN, Egeland J, Oie M. Learning and memory impairments in children and adolescents with attention-deficit/hyperactivity disorder. J Learn Disabil. 2013;46:453–60.CrossRefPubMed

31.

Crocker N, Vaurio L, Riley EP, Mattson SN. Comparison of verbal learning and memory in children with heavy prenatal alcohol exposure or attention-deficit⁄hyperactivity disorder. Alcohol Clin Exp Res. 2011;35:1114–21.CrossRefPubMedPubMedCentral

32.

Epstein JN, Brinkman WB, Froehlich T, Langberg JM, Narad ME, Antonini TN, et al. Effects of stimulant medication, incentives, and event rate on reaction time variability in children with ADHD. Neuropsychopharmacol. 2011;36:1060–72.CrossRef

33.

Barkley RA. Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol Bull. 1997;121:65–94.CrossRefPubMed

34.

Sonuga-Barke EJS. The dual pathway model of AD/HD: an elaboration of neuro-developmental characteristics. Neurosci Biobehav Rev. 2003;27:593–604.CrossRefPubMed

35.

Sonuga-Barke EJS, Bitsakou P, Thompson M. Beyond the dual pathway model: evidence for the dissociation of timing, inhibitory, and delay-related impairments in attention-deficit/hyperactivity disorder. J Am Acad Child Adol Psychiat. 2010;49:345–55.

36.

Sergeant J. The cognitive-energetic model: an empirical approach to attention-deficit hyperactivity disorder. Neurosci Biobeh Rev. 2000;24:7–12.CrossRef

37.

Karalunas SL, Geurts HM, Konrad K, Bender S, Nigg JT, Child J. Reaction time variability in ADHD and autism spectrum disorders: measurement and mechanisms of a proposed trans-diagnostic phenotype. J Child Psychol Psychiat. 2013;55:685–710.CrossRef

38.

Alderson RM, Kasper LJ, Hudec KL, Patros CHG. Attention-Deficit/Hyperactivity Disorder (ADHD) and working memory in adults: a meta-analytic review. Neuropsychol. 2013;27:287–302.CrossRef

39.

Bálint SB, Czobor P, Komlósi S., Mészáros Á, Simon V, Bitter I. Attention deficit hyperactivity disorder (ADHD): gender- and age-related differences in neurocognition. Psychol Med. 2009;39:1337–45.CrossRefPubMed

40.

Marx I, Hübner T, Herpertz SC, Berger C, Reuter E, Kircher T, et al. Cross-sectional evaluation of cognitive functioning in children, adolescents and young adults with ADHD. J Neur Transm. 2010;117:403–19.CrossRef

41.

Tucha L, Tucha O, Walitza S, Sontag TA, Laufkötter R, Linder M, et al. Vigilance and sustained attention in children and adults with ADHD. J Atten Disord. 2009;12:410–21.CrossRefPubMed

42.

Barnett R, Maruff P, Vance A, Luk ESL, Costin J, Wood C, et al. Abnormal executive function in attention deficit hyperactivity disorder: the effect of stimulant medication and age on spatial working memory. Psychol Med. 2001;31:1107–15.CrossRefPubMed

43.

Hodgkins P, Setyawan J, Mitra D, Davis K, Quintero J, Fridman M, et al. Management of ADHD in children across Europe: patient demographics, physician characteristics and treatment patterns. Eur J Pediatr. 2013;172:895–906.CrossRefPubMedPubMedCentral

44.

Kooij SJJ, Bejerot S, Blackwell A, Caci H, Casas-Brugué M, Carpentier PJ, et al. European consensus statement on diagnosis and treatment of adult ADHD: the European Network Adult ADHD. BMC Psychiat. 2010;10:1–24.CrossRef

45.

Trimbos Instituut. Multidisciplinaire richtlijn ADHD bij kinderen en jeugdigen, versie 1.0. Utrecht: Trimbos-instituut; 2005.

46.

Biederman J, Mick E, Surman C, Doyle R, Hammerness P, Harpold T, et al. A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. Biol Psychiat. 2006;59:829–35.CrossRefPubMed

47.

Spencer T, Biederman J, Wilens T, Doyle R, Surman C, Prince J, et al. A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder. Biol Psychiat. 2005;57:456–63.CrossRefPubMed

48.

Fusar-Poli P, Rubia K, Rossi G, Sartori G, Balottin U. Striatal dopamine transporter alterations in ADHD: pathophysiology or adaptation to psychostimulants? a meta-analysis. Am J Psychiat. 2012;169:264–72CrossRefPubMed

49.

Coghill DR, Seth S, Pedroso S, Usala T, Currie J, Gagliano A. Effects of methylphenidate on cognitive functions in children and adolescents with attention-deficit/hyperactivity disorder: evidence from a systematic review and a meta-analysis. Biol Psychiat. 2013;76:603–15.CrossRefPubMed

50.

Tamminga HGH, Reneman L, Huizenga HM, Geurts HM. Effects of methylphenidate on executive functioning in ADHD across the lifespan: a meta-regression analysis. submitted

51.

Stichting Farmaceutische Kengetallen. Flinke stijging volwassen gebruikers methylfenidaat. Den Haag: Stichting Farmaceutische Kengetallen; 2014.

52.

Andersen SL, Navalta CP. Altering the course of neurodevelopment: a framework for understanding the enduring effects of psychotropic drugs. Int J Dev Neurosci. 2004;39:1337–45.

53.

Bolaños CA, Willey MD, Maffeo ML, Powers KD, Kinka DW, Grausam KB, et al. Antidepressant treatment can normalize adult behavioral deficits induced by early-life exposure to methylphenidate. Biol Psychiat. 2008;63:309–16.CrossRefPubMed

54.

Vendruscolo LF, Izídio GS, Takahashi RN, Ramos A. Chronic methylphenidate treatment during adolescence increases anxiety-related behaviors and ethanol drinking in adult spontaneously hypertensive rats. Beh Pharmacol. 2008;19:21–7.CrossRef

55.

Nakao T, Radua J, Rubia K, Mataix-Cols D. Gray matter volume abnormalities in ADHD: voxel-based meta-analysis exploring the effects of age and stimulant medication. Am J Psychiat. 2011;168:1154–63.CrossRefPubMed

56.

Wang GJ, Volkow ND, Wigal T, Kollins SH, Newcorn JH, Telang F, et al. Long-term stimulant treatment affects brain dopamine transporter level in patients with attention deficit hyperactive disorder. Plos One. 2013;8:e63023CrossRefPubMedPubMedCentral

57.

Powers RL, Marks DJ, Miller CJ, Newcorn JH, Halperin JM. Stimulant treatment in children with attention-deficit/hyperactivity disorder moderates adolescent academic outcome. J Child Adol Psychopharmacol. 2008;18:449–59.CrossRef

58.

Semrud-Clikeman M, Pliszka S, Liotti M. Executive functioning in children with attention-deficit/hyperactivity disorder: combined type with and without a stimulant medication history. Neuropsychol. 2008;22:329–40.CrossRef

59.

Stoy M, Schlagenhauf F, Schlochtermeier L, Wrase J, Knutson B, Lehmkuhl U, et al. Reward processing in male adults with childhood ADHD – a comparison between drug-naïve and methylphenidate-treated subjects. Psychopharmacol. 2011;215:467–81.CrossRef

60.

Tamminga HGH, Reneman L, Bouziane C, Bottelier MA, Schrantee A, Geurts HM. Cognition in stimulant treatment-naïve boys and men with Attention-Deficit/Hyperactivity Disorder: an age perspective. submitted

61.

Bottelier MA, Schouw MLJ, Klomp A, Tamminga HGH, Schrantee AGM, Bouziane C, et al. The effects of Psychotropic Drugs on the Developing brain (ePOD) study: methods and design. BMC Psychiat. 2013;14:1–12.

62.

Valera EM, Brown A, Biederman J, Faraone SV, Makris N, Monuteaux MC, et al. Sex differences in the functional neuroanatomy of working memory in adults with ADHD. Am J Psychiat. 2010;167:86–94.CrossRefPubMedPubMedCentral

63.

Sonuga-Barke EJS, Coghill D, Markowitz JS, Swanson JM, Vandenberghe M, Hatch SJ. Seks differences in the response of children with ADHD to once-daily formulations of methylphenidate. J Am Acad Child Adolesc Psyciat. 2007;46:701–10.CrossRef

64.

Loo-Neus GHH van de, Rommelse N, Buitelaar JK. To stop or not to stop? How long should medication treatment of attention-deficit hyperactivity disorder be extended? Eur Neuropsychopharmacol. 2011;21:584–99.CrossRefPubMed

65.

Nigg JT, Willcutt EG, Doyle AE, Sonuga-Bark EJS. Causal heterogeneity in attention-deficit/hyperactivity disorder: do we need neuropsychologically impaired subtypes? Biol Psychiat. 2005;57:1224–30.CrossRefPubMed

66.

Sjöwall D, Roth L, Lindqvist S, Thorell LB. Multiple deficits in ADHD: executive dysfunction, delay aversion, reaction time variability, and emotional deficits. J Child Psychol Psychiat. 2013;54:619–27.CrossRefPubMedPubMedCentral

67.

Dovis S, Oord S van der, Huizenga HM, Wiers RW, Prins PJM. Prevalence and diagnostic validity of motivational impairments and deficits in visuospatial short-term memory and working memory in ADHD subtypes. Eur Child Adol Psychiat. (in press)

68.

Zeeuw P de, Weusten J, Dijk S van, Belle J van, Durston S. Deficits in cognitive control, timing and reward sensitivity appear to be dissociable in ADHD. Plos One. 2012;7:1–12.

69.

Lijffijt M, Kenemans L, Verbaten MN, Engeland H van. A meta-analytic review of stopping performance in attention-deficit/hyperactivity disorder: deficient inhibitory motor control? J Abnorm Psychol. 2005;114:216–22.CrossRefPubMed

70.

McLean A, Dowson J, Toone B, Young S, Bazanis B, Robbins TW, et al. Characteristic neurocognitive profile associated with adult attention-deficit/hyperactivity disorder. Psychol Med. 2004;34:681–92.CrossRefPubMed

71.

Hulst BM van, Zeeuw P de, Durston S. Distinct neuropsychological profiles within ADHD: a latent class analysis of cognitive control, reward sensitivity and timing. Psychol Med. 2015;45:735–45.CrossRefPubMed

72.

Mostert JC, Onnink AMH, Klein M, Dammers J, Harneit A, Schulten T, et al. Cognitive heterogeneity in adult attention deficit/hyperactivity disorder: a systematic analysis of neuropsychological measurements. Eur Neuropsychopharmacol. advance online publication.

73.

Huizenga HM, Smeding H, Grasman RPPP, Schmand B. Multivariate normative comparisons. Neuropsychologia. 2007;45:2534–42.CrossRefPubMed

74.

Tamminga HGH, Reneman L, Schmand B, Geurts HM. Serial assessment with experimental cognitive tests in normal children and adults: test-retest reliability and reliable change. submitted

Titel: Is er een typisch neuropsychologisch profiel bij volwassenen met ADHD? Een ontwikkelingsperspectief
Auteurs: Hyke G. H. Tamminga
Hilde M. Geurts
Publicatiedatum: 11-01-2016
Uitgeverij: Bohn Stafleu van Loghum
Gepubliceerd in: Neuropraxis / Uitgave 1/2016
Print ISSN: 1387-5817
Elektronisch ISSN: 1876-5785
DOI: https://doi.org/10.1007/s12474-015-0110-3

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Samenvatting

Log in om toegang te krijgen

Andere artikelen Uitgave 1/2016

Waarom volwassenen met ADHD vaak te laat komen op afspraken – is het een beperking in de tijdwaarneming of het geheugen?

ADHD bij volwassenen: ontwikkelingen in Nederland en Europa

Inleiding bij het themanummer ADHD bij volwassenen

Whole body vibration als nieuwe behandeling voor cognitieve disfuncties bij ADHD?

Autorijden met ADHD

Woorden vooraf